Clinical Trials Logo

Clinical Trial Summary

The purpose of this research is to evaluate the efficacy and safety of Robot-assisted rehabilitation intelligent system as a virtual stand-alone treatment, delivered with minimal clinical monitoring compared with treatment as usual in methamphetamine (MA) use disorders.


Clinical Trial Description

Based on artificial intelligence technology, face recognition technology, virtual reality technology to develop an available Robot-assisted rehabilitation intelligent system. Then, using this intelligent system as a new way of Psychotherapy to provide treatment for methamphetamine patients, and compare it with traditional treatment to verify the efficacy and safety of Robot-assisted rehabilitation intelligent system in Chinese methamphetamine patients. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04531384
Study type Interventional
Source Shanghai Mental Health Center
Contact Min Zhao
Phone 64387250
Email drminzhao@gmail.com
Status Recruiting
Phase N/A
Start date December 1, 2020
Completion date December 2022

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05535101 - Non-invasive Brain Stimulation in Patients With Methamphetamine Use Disorder N/A
Not yet recruiting NCT02836756 - Cannabidiol as a New Intervention for Amphetamine Dependence Phase 2
Completed NCT03318081 - The Application of Cognitive Rehabilitation Therapy for Amphetamine-type Stimulants Addiction N/A
Completed NCT03221283 - The Application of Music Therapy in Female Amphetamine Use Disorder N/A
Withdrawn NCT02952196 - Cannabioids as a New Intervention for Amphetamine Dependence Phase 2
Completed NCT02285556 - The Diagnostic Assessment and Intervention Study of Amphetamine Type Stimulus N/A
Completed NCT02713815 - Novel Intervention for Amphetamine-type Stimulants Addiction N/A
Completed NCT00713479 - An Assessment of the Safety of Varenicline in Methamphetamine-dependent Volunteers Phase 1
Completed NCT04993300 - Repetitive Transcranial Magnetic Stimulation in Amphetamine Addiction N/A
Completed NCT02950376 - The Novel Addiction Assessment Study in Synthetic Drugs Addiction
Recruiting NCT04687566 - Dextromethorphan, Memantine Monotherapy, or Combined Use of Dextromethorphan and Memantine in Amphetamine Addiction Phase 2/Phase 3